Galapagos : Publication of the annual report and invitation to the ... Investors: Elizabeth Goodwin VP Investor Relations +1 781 460 1784. Galapagos Capital Markets Day 2021 Basic … EN; FR; IT; Investor Dashboard. For more information on shareholder services, Investment Program and shareholder requests. Galapagos NV (GLPG) CEO Onno van de Stolpe on Q4 2021 Results - Earnings Call Transcript. RelSci Relationships. +32 485 19 14 15 Email: ir@glpg.com. Galapagos - homepage Investors | Corporate. Galapagos NV, a clinical-stage biotechnology company, discovers, develops, and commercializes various small molecule medicines. Skip to main navigation SEC Filings SEC Filing Keyword Search. This overview only concerns the non-consolidated statutory results of Galapagos NV. These results are part of the consolidated results as discussed in the letter from the management. Galapagos NV’s operating income in 2019 amounted to €1,324.3 million compared to €513.1 million in 2018.